Exicure, Inc. Profile Avatar - Palmy Investing

Exicure, Inc.

Exicure, Inc., a biotechnology company, develops therapies for neurological disorders and hair loss based on its proprietary spherical nucleic acid (SNA) technology. Its lead program candidate includes SCN9A that is in preclinical studies for neuropathic…

Biotechnology
US, Chicago [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Exicure, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Exicure, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Exicure, Inc..

End of XCUR's Analysis
CIK: 1698530 CUSIP: 30205M101 ISIN: US30205M2008 LEI: - UEI: -
Secondary Listings
XCUR has no secondary listings inside our databases.